202 related articles for article (PubMed ID: 19150414)
21. Genetic testing by cancer site: pancreas.
Axilbund JE; Wiley EA
Cancer J; 2012; 18(4):350-4. PubMed ID: 22846737
[TBL] [Abstract][Full Text] [Related]
22. Genetic Syndromes with Pancreatic Manifestations.
Pittman ME; Brosens LA; Wood LD
Surg Pathol Clin; 2016 Dec; 9(4):705-715. PubMed ID: 27926368
[TBL] [Abstract][Full Text] [Related]
23. Evidence for a major gene influencing risk of pancreatic cancer.
Klein AP; Beaty TH; Bailey-Wilson JE; Brune KA; Hruban RH; Petersen GM
Genet Epidemiol; 2002 Aug; 23(2):133-49. PubMed ID: 12214307
[TBL] [Abstract][Full Text] [Related]
24. Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals.
Matsubayashi H
J Gastroenterol; 2011 Nov; 46(11):1249-59. PubMed ID: 21847571
[TBL] [Abstract][Full Text] [Related]
25. Well-differentiated Pancreatic Neuroendocrine Tumor in a Patient With Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM).
Noë M; Hackeng WM; de Leng WWJ; Vergeer M; Vleggaar FP; Morsink FHM; Wood LD; Hruban RH; Offerhaus GJA; Brosens LAA
Am J Surg Pathol; 2019 Sep; 43(9):1297-1302. PubMed ID: 31261289
[TBL] [Abstract][Full Text] [Related]
26. Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor.
Goehringer C; Sutter C; Kloor M; Gebert J; Slater EP; Keller M; Treiber I; Ganschow P; Kadmon M; Moog U
Fam Cancer; 2017 Apr; 16(2):303-309. PubMed ID: 27838800
[TBL] [Abstract][Full Text] [Related]
27. The genetics of pancreatic cancer.
Cowgill SM; Muscarella P
Am J Surg; 2003 Sep; 186(3):279-86. PubMed ID: 12946833
[TBL] [Abstract][Full Text] [Related]
28. Molecular biology of pancreatic cancer.
Zavoral M; Minarikova P; Zavada F; Salek C; Minarik M
World J Gastroenterol; 2011 Jun; 17(24):2897-908. PubMed ID: 21734801
[TBL] [Abstract][Full Text] [Related]
29. CDKN2A is the main susceptibility gene in Italian pancreatic cancer families.
Ghiorzo P; Fornarini G; Sciallero S; Battistuzzi L; Belli F; Bernard L; Bonelli L; Borgonovo G; Bruno W; De Cian F; Decensi A; Filauro M; Faravelli F; Gozza A; Gargiulo S; Mariette F; Nasti S; Pastorino L; Queirolo P; Savarino V; Varesco L; Scarrà GB;
J Med Genet; 2012 Mar; 49(3):164-70. PubMed ID: 22368299
[TBL] [Abstract][Full Text] [Related]
30. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance.
Kluijt I; Cats A; Fockens P; Nio Y; Gouma DJ; Bruno MJ
J Clin Gastroenterol; 2009 Oct; 43(9):853-7. PubMed ID: 19417680
[TBL] [Abstract][Full Text] [Related]
31. [Hereditary pancreatic cancer].
Habbe N; Langer P; Bartsch DK
Chirurg; 2008 Nov; 79(11):1029-37. PubMed ID: 18818893
[TBL] [Abstract][Full Text] [Related]
32. Hereditary cancer syndrome diagnosis: molecular genetic clues and cancer control.
Lynch HT; Fusaro RM; Lynch JF
Future Oncol; 2007 Apr; 3(2):169-81. PubMed ID: 17381417
[TBL] [Abstract][Full Text] [Related]
33. Familial pancreatic cancer.
Shi C; Hruban RH; Klein AP
Arch Pathol Lab Med; 2009 Mar; 133(3):365-74. PubMed ID: 19260742
[TBL] [Abstract][Full Text] [Related]
34. Current Approaches to Pancreatic Cancer Screening.
Chhoda A; Lu L; Clerkin BM; Risch H; Farrell JJ
Am J Pathol; 2019 Jan; 189(1):22-35. PubMed ID: 30558719
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of pancreatic cancer: an overview.
Ghadirian P; Lynch HT; Krewski D
Cancer Detect Prev; 2003; 27(2):87-93. PubMed ID: 12670518
[TBL] [Abstract][Full Text] [Related]
36. BRCA1 and pancreatic cancer: pedigree findings and their causal relationships.
Lynch HT; Deters CA; Snyder CL; Lynch JF; Villeneuve P; Silberstein J; Martin H; Narod SA; Brand RE
Cancer Genet Cytogenet; 2005 Apr; 158(2):119-25. PubMed ID: 15796958
[TBL] [Abstract][Full Text] [Related]
37. Targeted therapy for hereditary cancer syndromes: hereditary breast and ovarian cancer syndrome, Lynch syndrome, familial adenomatous polyposis, and Li-Fraumeni syndrome.
Agarwal R; Liebe S; Turski ML; Vidwans SJ; Janku F; Garrido-Laguna I; Munoz J; Schwab R; Rodon J; Kurzrock R; Subbiah V;
Discov Med; 2014 Dec; 18(101):331-9. PubMed ID: 25549704
[TBL] [Abstract][Full Text] [Related]
38. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).
Vasen HF; Gruis NA; Frants RR; van Der Velden PA; Hille ET; Bergman W
Int J Cancer; 2000 Sep; 87(6):809-11. PubMed ID: 10956390
[TBL] [Abstract][Full Text] [Related]
39. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
40. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.
Poley JW; Kluijt I; Gouma DJ; Harinck F; Wagner A; Aalfs C; van Eijck CH; Cats A; Kuipers EJ; Nio Y; Fockens P; Bruno MJ
Am J Gastroenterol; 2009 Sep; 104(9):2175-81. PubMed ID: 19491823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]